The Global Sepsis Diagnostics Market was valued at USD 369.56 million in 2016 and is projected to reach USD 779.74 million by 2025, growing at a CAGR of 8.65% from 2017 to 2025.
Sepsis is among the most common causes of death in hospitals. It arises from the host response to infection. Currently, diagnosis relies on nonspecific physiological criteria and culture-based pathogen detection. This problem is tackled by sepsis diagnostics where there is efficient detection and treatment of septic wounds, Thereby increasing the value of the market through medicinal benefits.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Prevalence of sepsis cases in neonatal and adult population
1.2 Growing demand of sepsis care in geriatric population
1.3 Increasing number of pre gestation period end births
1.4 High number of infections and hospital acquired infections
1.5 Increasing ratio of surgeries
1.6 High number pf pneumonia cases
1.7 Convenience provided by new technologies of curing and diagnosing sepsis
2. Market Restraints
2.1 High cost of devices
2.2 Reimbursement Issues
Market Segmentation:
1. Global Sepsis Diagnostics Market, by Technology:
1.1 Microbiology
1.2 Molecular Diagnostics
1.3 Immunoassays
1.4 Flow Cytometry
2. Global Sepsis Diagnostics Market, by Product:
2.1 Instruments
2.2 Blood Culture Media
2.3 Assay Kits & Reagents
2.4 Software
3. Global Sepsis Diagnostics Market, by Usability:
3.1 Laboratory Testing
3.2 Point-Of-Care Testing
4. Global Sepsis Diagnostics Market, by Method:
4.1 Conventional Diagnostics
4.2 Automated Diagnostic
5. Global Sepsis Diagnostics Market, by Pathogen:
5.1 Bacterial Sepsis
5.1.1 Gram-Negative Bacterial Sepsis
5.1.2 Gram-Positive Bacterial Sepsis
5.2 Fungal Sepsis
5.3 Other Pathogen Infections
6. Global Sepsis Diagnostics Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Biomerieux SA
2. Becton, Dickinson and Company
3. Thermo Fisher Scientific Inc.
4. Abbott Laboratories, Inc.
5. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
6. Cepheid Inc.
7. T2 Biosystems, Inc.
8. Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
9. Nanosphere, Inc. (A Luminex Company)
10. Bruker Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Sepsis Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL SEPSIS DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL SEPSIS DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
5.1 Microbiology
5.2 Molecular Diagnostics
5.3 Immunoassays
5.4 Flow Cytometry
6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT
6.1 Instruments
6.2 Blood Culture Media
6.3 Assay Kits & Reagents
6.4 Software
7 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY USABILITY
7.1 Laboratory Testing
7.2 Point-Of-Care Testing
8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY METHOD
8.1 Conventional Diagnostics
8.2 Automated Diagnostic
9 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
9.1 Bacterial Sepsis
9.1.1 Gram-Negative Bacterial Sepsis
9.1.2 Gram-Positive Bacterial Sepsis
9.2 Fungal Sepsis
9.3 Other Pathogen Infections
10 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL SEPSIS DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Biomerieux SA
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Becton, Dickinson and Company
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Thermo Fisher Scientific Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Abbott Laboratories, Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Roche Diagnostics Limited
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Cepheid Inc.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 T2 Biosystems, Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Beckman Coulter, Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Nanosphere, Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Bruker Corporation
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Reports
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The In Vitro Diagnostics Analyzers Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Tuberculosis Diagnostics Testing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Companion Animal Diagnostics Imaging Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The In Vitro Diagnostics (IVD) Tests For Autoimmune Diseases Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, c...
The Digital Diagnostics System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Liver Disease Diagnostics Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...